Sarepta Therapeutics, Inc.
215 First Street
Cambridge, MA -2142
United States
884 articles about Sarepta Therapeutics, Inc.
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Holds Its Breath as Feds Order Halt to Ebola Work
8/8/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Announces Second Quarter 2012 Financial Results and Recent Corporate Developments
8/8/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) to Ring the NASDAQ Stock Market Closing Bell
8/7/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) to Present Company Overview at the 32nd Canaccord Genuity Annual Growth Conference
8/3/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) to Present Company Overview at the Wedbush PacGrow Life Sciences Management Access Conference
7/31/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Announces Second Quarter 2012 Financial Results and Corporate Update Conference Call
7/31/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Regains NASDAQ Compliance
7/27/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.)'s Muscular Dystrophy Drug Improves With Time
7/25/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) Announces Conference Call and Webcast on Tuesday, July 24, 2012, to Discuss 36-Week 6-Minute Walk Test Results From the Phase IIb DMD Study
7/24/2012
-
Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.)'s Marburg Virus Drug Shows Survival in Primates Despite Delayed Treatment
7/19/2012
-
AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics (Formerly known as AVI BioPharma, Inc.) and Stock Ticker Symbol Change to "SRPT" Effective Today
7/12/2012
-
AVI BioPharma, Inc. to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference
7/9/2012
-
AVI BioPharma, Inc. and Parent Project Muscular Dystrophy Team Up to Run Seattle Marathon & Raise Money to End Duchenne
6/21/2012
-
AVI BioPharma, Inc. Receives NASDAQ Notice of Minimum Bid Price Non-Compliance
6/4/2012
-
AVI BioPharma, Inc. Announces First Quarter 2012 Financial Results and Recent Corporate Developments
5/11/2012
-
AVI BioPharma, Inc. Announces First Quarter 2012 Financial Results and Corporate Update Conference Call
5/3/2012
-
GlobalData Release: AVI BioPharma, Inc.'s Eteplirsen Conundrum
4/30/2012
-
AVI BioPharma, Inc. to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystrophy at the 2012 American Academy of Neurology Annual Meeting
4/25/2012
-
AVI BioPharma, Inc.: Eteplirsen Study Shows No Significant Improvement in Walking
4/2/2012
-
Data From AVI BioPharma, Inc.'s Infectious Disease Programs to be Presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases
3/30/2012